Anteris Technologies Ltd
Anteris Technologies hails FDA early feasibility study approval for DurAVR™
EQS-News: Anteris Technologies Ltd
Contact DetailsProactive Investors Jonathan Jackson +61 413 713 744 Jonathan@proactiveinvestors.com News Source: News Direct
06.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. |
Language: | English |
Company: | Anteris Technologies Ltd |
United States | |
ISIN: | AU000000AHZ5 |
EQS News ID: | 1506645 |
End of News | EQS News Service |